about
Aspirin resistance: does it exist?Influence of thrombolytic agents on human platelet function.Comparison of relative waist circumference between Asian Indian and US adults.Chronomics: circadian and circaseptan timing of radiotherapy, drugs, calories, perhaps nutriceuticals and beyond.Intracerebral hemorrhage: a review of coagulation function.Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population.Biochemistry, physiology, and function of platelets stored as concentrates.Antioxidants, atherosclerosis and thrombosis.Thermosensitization by increasing intracellular acidity with amiloride and its analogs.Reduction of ferric heme to ferrous by lipid peroxides: possible relevance to the role of peroxide tone in the regulation of prostaglandin synthesis.Irreversible platelet aggregation does not depend on lipoxygenase metabolites.Vessel wall arachidonate metabolism after angioplasty: possible mediators of postangioplasty vasospasm.Influence of calcium antagonists on thrombin-induced calcium mobilization and platelet-vessel wall interactions.Measurement of ionized calcium in normal human blood platelets.Influence of heparins on inositol 1,4,5-trisphosphate-induced calcium mobilization in permeabilized human platelets.Differential response of human and bovine platelets to bovine von Willebrand factor and vascular subendothelium.A new platelet preservative.Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery.The development of porous alginate/elastin/PEG composite matrix for cardiovascular engineering.Platelet storage solution improves the in vitro function of preserved platelet concentrate.The immunogenic potential of generic version of low-molecular-weight heparins may not be the same as the branded products.Evaluation of the coagulation profile among oral and vaginal combined hormonal contraceptive users using sonoclot coagulation analyzer.Inhibition of prostaglandin (PG) synthesis in sheep vesicular gland microsomes (SVGM) by nitroblue tetrazolium (NBT) and vitamin E (VE)Comparative pharmacology of cyclooxygenase inhibitors on platelet functionRole of arachidonic acid metabolism in human platelet activation and irreversible aggregationLabile aggregation stimulating substance (LASS): the factor from storage pool deficient platelets correcting defective aggregation and release of aspirin treated normal plateletsThe role of iron in prostaglandin synthesis: ferrous iron mediated oxidation of arachidonic acidArachidonic acid peroxidation, prostaglandin synthesis and platelet functionAn improved method for measuring endogenous serotonin in platelets of patients with Hermansky-Pudlak syndromeSmoking and platelet labile aggregation stimulating substance (LASS) synthesizing activityAspirin, prostaglandin E1 and Quin-2 AM-induced platelet dysfunction: restoration of function by noradrenalinEpinephrine-induced reversal of aspirin effects on platelet deformabilityRapid separation of tumor-promoting agents, phorbol and phorbol myristate acetate (12-o-tetradecanoylphorbol-13-acetate) by high-pressure liquid chromatographyInfluence of nitric oxide on agonist-mediated calcium mobilization in plateletsInfluence of phospholipase A2 on human blood platelet alpha adrenergic receptor functionInfluence of a calcium dependent protease inhibitor on platelet activation and secretionInfluence of calmodulin antagonist (stelazine) on agonist-induced calcium mobilization and platelet activationAflatoxin detection by high-speed liquid chromatography and mass spectrometryThe influence of glutathione depleting agents on human platelet functionEpinephrine reverses the inhibitory influence of aspirin on platelet-vessel wall interactions
P50
Q28220132-983D80B6-ABBA-4EA9-B3A5-E5DDE544DF90Q33356282-CCEF96DD-288D-46B7-AB0F-25E5DACF0A60Q34307615-28359FA9-2122-4CEB-B12C-29B857568A49Q35594637-59E2BFBC-F22F-4796-9AEC-3847A7951676Q38035818-F880F2ED-1ECB-4794-A45F-DBDD63BD3DD7Q39702873-030DA6D5-0BFA-4095-9A53-83D89CDAAF4EQ40767408-F950C6F5-7705-4478-BADB-D3974EB935D4Q41154173-30DD3931-4C00-49EF-8838-250A386AEA71Q41418221-A68DE7FC-9583-4FC6-A4F8-573A97E39507Q41644744-F3CB24EC-2F04-47BC-91F5-2230107FD732Q42226094-5281123C-5976-42CC-A22E-48106AA5A714Q42244134-EDFF1A1F-11BC-4CC8-9920-10E3EB560584Q42461859-6E89EBDD-3C72-44FB-BA6D-7B1779E5F67EQ42518923-31D3D428-F34A-4F51-BE6A-0BD7881B60E5Q43416855-2663954C-5291-4457-9B15-0575BAA813CDQ43576408-9BE9560A-2B3A-415F-A863-55404FB081ACQ44253011-8DE526E0-DEB6-4CE5-9A39-D4AF1A73BE7EQ44420349-DEFD4BA0-B8F6-40F3-AB04-D12C31CA8546Q44471943-302938D0-0A15-452A-BD3F-4F0B63E083DBQ44665819-EC02BC3B-0A57-4607-B0AD-B7065928E0F2Q47253148-34502BDF-57BE-4A44-8AE3-2298C8EA05D3Q51365511-FBD763B6-525C-49F5-BF7D-C9A843A4CDF0Q67005845-6AE04B54-99FF-4CE9-8D91-B738586D55DDQ67292223-154672B5-F422-4834-9F52-AB8DAA2AE643Q67302009-31834C30-6978-46AF-AAE2-D676E2038F47Q67337265-D07B78BA-4358-48CF-96FE-314AA07558BEQ67411308-FB54CFE8-D5F5-4D53-B017-EE1519C92FF7Q67432148-B8B7D88F-44E7-4C67-90E4-4296E5F84A5DQ67963656-33E5ECF8-FCCF-4302-B2B0-7E272660768AQ68223432-873814EE-F703-4D37-B261-B273CA5A24C2Q68460883-AA9A6D31-0623-467E-8B45-246D36E608C4Q68495957-B00922F3-D67E-411B-ACC9-F55277AC5A64Q68698050-6D122DAF-73C2-4484-8870-69843954DBD4Q68881712-9048A12B-019F-42C0-A5BB-7FEB1F5832FDQ69350828-0F18445A-FCE3-4EC3-BFF8-08E7B3F42364Q69458820-92E30039-A990-4601-935E-8F6DCFFE37E6Q69464020-510E734B-E69D-411F-BB94-10112C5839FBQ69596219-95D2AE4B-BEF8-4FB8-8BC6-F63B2A648FCDQ69633515-E933A915-E230-4174-A016-28F9FF5CD6CFQ69676965-03B32EE5-DC36-4A6B-9ADD-88EA3B32DF01
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gundu Rao
@ast
Gundu Rao
@en
Gundu Rao
@es
Gundu Rao
@nl
type
label
Gundu Rao
@ast
Gundu Rao
@en
Gundu Rao
@es
Gundu Rao
@nl
prefLabel
Gundu Rao
@ast
Gundu Rao
@en
Gundu Rao
@es
Gundu Rao
@nl
P106
P1153
7403993477
P31
P496
0000-0002-2692-7950